Mitchell R. McGill

Federal Grant PI High Impact

Assistant Professor

Last publication 2025 Last refreshed 2026-05-22

faculty

Environmental Health Sciences, College of Public Health

46 h-index 148 pubs 12,250 cited

Biography and Research Information

OverviewAI-generated summary

Mitchell R. McGill's research focuses on understanding the mechanisms of drug-induced liver injury, with a particular emphasis on acetaminophen overdose. He investigates the role of cellular metabolism and signaling pathways in the progression and resolution of liver damage. His work explores the generation of inflammatory mediators and the identification of prognostic biomarkers in patients with acute liver failure.

Dr. McGill's federally funded research, supported by a $328,034 grant from the NIH/National Institute of Diabetes and Digestive and Kidney Diseases, specifically examines the role of phosphatidic acid in liver regeneration following acetaminophen overdose. He also studies the hepatotoxicity associated with herbal dietary supplements and the potential for repeated acetaminophen use in patients with liver conditions.

His scholarly contributions include a significant publication record, with an h-index of 45 and over 9,500 citations across 148 publications. Dr. McGill collaborates with researchers at the University of Arkansas for Medical Sciences, including Stefanie Kennon‐McGill, Eric U. Yee, Igor Koturbash, and Felicia D. Allard, with whom he has co-authored multiple publications.

Metrics

  • h-index: 46
  • Publications: 148
  • Citations: 12,250

Selected Publications

  • Special Issue “Mechanistic and Prognostic Biomarkers in Liver Diseases” (2025)
  • From fructose to the future: liver disease biomarkers and their prognostic value in acute liver failure (2025)
    1 citation DOI OpenAlex
  • Detection and Diagnosis of Hepatotoxicity in Experimental and Clinical Settings (2025)
  • Kupffer cell expression of macrophage receptor with collagenous structure modulates macrophage gene induction and limits acute liver injury (2025)
    1 citation DOI OpenAlex
  • NAPQI is absent in the mouse brain after sub-hepatotoxic and hepatotoxic doses of acetaminophen (2025)
    3 citations DOI OpenAlex
  • Minimally invasive clinical biomarkers for use in acetaminophen hepatotoxicity (2024)
    1 citation DOI OpenAlex
  • Intracellular signaling mechanisms of acetaminophen-induced cell death (2024)
  • Translation of acetaminophen hepatotoxicity mechanisms from models to humans (2024)
  • Serum glutamate dehydrogenase activity enables sensitive and specific diagnosis of hepatocellular injury in humans (2024)
    5 citations DOI OpenAlex
  • Human quad liver-on-chip system as a tool toward bridging the gap between animals and humans regarding toxicology and pharmacology of a cannabidiol-rich cannabis extract (2024)
    3 citations DOI OpenAlex
  • Natural Products That Protect Against Acetaminophen Hepatotoxicity: A Call for Increased Rigor in Preclinical Studies of Dietary Supplements (2024)
    2 citations DOI OpenAlex
  • The Role of Mechanistic Biomarkers in Understanding Acetaminophen Hepatotoxicity in Humans (2023)
    10 citations DOI OpenAlex
  • The Evolution of Circulating Biomarkers for Use in Acetaminophen/Paracetamol-Induced Liver Injury in Humans: A Scoping Review (2023)
    12 citations DOI OpenAlex
  • Hepatic pyruvate and alanine metabolism are critical and complementary for maintenance of antioxidant capacity and resistance to oxidative insult (2023)
    25 citations DOI OpenAlex
  • Hands-Free Analytical Urine Testing Technology Validated for Drug-Facilitated Crime Investigations (2023)
    4 citations DOI OpenAlex

View all publications on OpenAlex →

Federal Grants 1 $328,034 total

NIH/National Institute of Diabetes and Digestive and Kidney Diseases Contact PI Mar 2024 - Feb 2029

The role of phosphatidic acid in liver regeneration after acetaminophen overdose

National Institute of Diabetes and Digestive and Kidney Diseases $328,034 R01

Grants & Funding

  • In-vitro assessment of the protective effects of selected ingredients against acetaminophen hepatotoxicity Haleon PLC Principal Investigator
  • The role of phosphatidic acid in liver regeneration after acetaminophen overdose NIH Principal Investigator
  • The role of phosphatidic acid in liver regeneration after acetaminophen overdose NIH/Nat. Inst. of Diabetes & Digestive & Kidney Diseases Principal Investigator

Collaboration Network

114 Collaborators 39 Institutions 3 Countries

Top Collaborators

View profile →
View profile →
View profile →
View profile →

Similar Researchers

Based on overlapping research topics